Advertisement
Advertisement

MGRX

MGRX logo

Mangoceuticals Inc

2.44
USD
-0.14
-5.43%
Dec 18, 15:59 UTC -5
Closed
...

Mangoceuticals Inc Profile

About

Mangoceuticals Inc. is involved in developing, marketing and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction drug branded `Mango`. Mangoceuticals Inc. is based in DALLAS, TX.

Info & Links

CEO

Jacob D. Cohen

Headquarters

15110 N.DALLAS PKWY, SUITE 600
DALLAS, TX 75248, UNITED STATES

Auditor

Turner, Stone & Company, L.L.P.

Share holders

34

Employees

--

Mangoceuticals Inc Statistics

Valuation Measures

Market Capitalization2

6.08M

Enterprise Value

6.19M

Enterprise Value/EBITDA(ttm)

-0.65

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

8.61

Price to Book(mrq)

0.39

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

57.99%

Operating Margin(ttm)

-1237.00%

Profit Margin(ttm)

-1280.29%

Return on Equity(ttm)

-138.00%

Return on Invested Capital(ttm)

-116.67%

Return on Assets(ttm)

-118.88%

Income Statement

Revenue(ttm)

755.10K

Revenue Per Share(ttm)

0.30

Gross Profit(ttm)

442.50K

EBITDA(ttm)3

-9.55M

Net Income Available to Common(ttm)

-9.33M

Diluted EPS(ttm)

-5.79

Share Statistics

Beta (5Y Monthly)

2.09

52-Week Change

-76.32%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

2.49M

Dividend Yield

0.00%

Float4

1.51M

% Held by Insiders

39.30%

% Held by Institutions

56.72%

Balance Sheet

Total Cash(mrq)

73.90K

Total Cash Per Share(mrq)

0.03

Total Debt(mrq)

187.50K

Total Debt/Equity(mrq)

1.40%

Current Ratio(mrq)

0.07%

Quick Ratio(mrq)

0.07%

Book Value Per Share(mrq)

6.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.85

Free Cash Flow(ytd)

-3.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement